Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)

Ítems similars

• Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa
  per: Kiang, Anna-Sophia, et al.
  Publicat: (2020)
• Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa
  per: Millington-Ward, Sophia, et al.
  Publicat: (2011)
• C1q enhances cone photoreceptor survival in a mouse model of autosomal recessive retinitis pigmentosa
  per: Humphries, Marian M, et al.
  Publicat: (2012)
• Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy
  per: Kenna, Paul F, et al.
  Publicat: (2020)
• Autosomal dominant retinitis pigmentosa: no evidence for nonallelic genetic heterogeneity on 3q.
  per: Kumar-Singh, R, et al.
  Publicat: (1993)